Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Passage BIO, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q2 2024
- Shares held
- 38.7M
- −792.8K (−2.0%) vs. Q2 2024
- Total value
- $27.1M
- −$4.28M (−13.7%) vs. Q2 2024
- New holders
- 10
- 8 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 47 | $33 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 60 | $42 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 64 | $45 | 0.00% | +64 | New |
| LRI Investments, LLC | 225 | $133 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 273 | $191 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 425 | $298 | 0.00% | +58+15.8% | Added |
| Federated Hermes, Inc. | 783 | $548 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,770 | $1.24K | 0.00% | +1,770 | New |
| Nordwand Advisors, LLC | 2,500 | $1.75K | 0.00% | +2,500 | New |
| Tower Research Capital LLC (TRC) | 5,030 | $3.52K | 0.00% | −8,173−61.9% | Reduced |
| Jane Street Group, LLC | 12,271 | $8.59K | 0.00% | +12,271 | New |
| Barclays PLC | 13,153 | $9.21K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 13,442 | $9.41K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 16,380 | $11.0K | 0.00% | −5,132−23.9% | Reduced |
| Two Sigma Securities, LLC | 21,635 | $15.1K | 0.00% | +21,635 | New |
| FMR LLC | 22,852 | $16.0K | 0.00% | +1,798+8.5% | Added |
| Cresset Asset Management, LLC | 23,725 | $16.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,072 | $18.9K | 0.00% | −161−0.6% | Reduced |
| Squarepoint Ops LLC | 27,927 | $19.5K | 0.00% | +27,927 | New |
| XTX Topco Ltd | 29,590 | $20.7K | 0.00% | +12,551+73.7% | Added |
| Engineers Gate Manager LP | 34,770 | $24.3K | 0.00% | +34,770 | New |
| Northern Trust Corp | 40,281 | $28.2K | 0.00% | −24,231−37.6% | Reduced |
| Landscape Capital Management, L.L.C. | 53,915 | $37.7K | 0.00% | +53,915 | New |
| DLK Investment Management, LLC | 64,000 | $44.8K | 0.02% | 00.0% | Unchanged |
| Shay Capital LLC | 92,256 | $64.6K | 0.02% | +92,256 | New |
| Two Sigma Investments, LP | 98,041 | $68.6K | 0.00% | −5,813−5.6% | Reduced |
| State Street Corp | 123,873 | $86.7K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 142,807 | $100.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 163,859 | $114.7K | 0.00% | −587,067−78.2% | Reduced |
| Fiduciary Trust Co | 215,000 | $150.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 402,525 | $281.8K | 0.00% | +244,264+154.3% | Added |
| Geode Capital Management, LLC | 509,516 | $356.7K | 0.00% | +78,406+18.2% | Added |
| Bridgeway Capital Management, LLC | 556,142 | $389.3K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 721,735 | $505.2K | 0.00% | +721,735 | New |
| Acadian Asset Management LLC | 961,271 | $671.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,392,846 | $975.0K | 0.00% | +267,272+23.7% | Added |
| Tang Capital Management LLC | 1,500,000 | $1.05M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,071,538 | $1.45M | 0.00% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,455,800 | $1.72M | 0.02% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1.75M | 1.80% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 6,100,000 | $4.27M | 0.34% | +48,000+0.8% | Added |
| Lynx1 Capital Management LP | 8,426,955 | $5.90M | 2.09% | +3,369,326+66.6% | Added |
| OrbiMed Advisors LLC | 9,822,876 | $6.88M | 0.13% | −301,700−3.0% | Reduced |
| Versant Venture Management, LLC | 0 | $0 | 0.00% | −4,026,417−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −471,812−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −264,266−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −85,500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −693−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,146−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −783−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |